Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 11.71B | 11.71B | 8.03B | 7.37B | 5.76B | 4.33B |
Gross Profit | 4.52B | 4.52B | 4.73B | 4.60B | 3.57B | 2.93B |
EBITDA | 3.15B | 2.77B | 3.10B | 2.70B | 2.30B | 1.58B |
Net Income | 2.04B | 2.04B | 1.98B | 1.85B | 1.53B | 1.13B |
Balance Sheet | ||||||
Total Assets | 20.95B | 20.95B | 20.34B | 18.43B | 16.88B | 7.84B |
Cash, Cash Equivalents and Short-Term Investments | 6.55B | 6.55B | 1.74B | 2.55B | 6.83B | 1.33B |
Total Debt | 27.00M | 27.00M | 54.33M | 7.13M | 13.03M | 11.02M |
Total Liabilities | 5.08B | 5.08B | 5.61B | 3.63B | 3.07B | 2.75B |
Stockholders Equity | 15.83B | 15.83B | 14.69B | 13.42B | 13.78B | 5.06B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.70B | 9.71M | -183.60M | 217.12M | 1.68B |
Operating Cash Flow | 3.74B | 3.31B | 932.45M | 848.20M | 944.25M | 1.90B |
Investing Cash Flow | -2.64B | -2.21B | 165.94M | -1.41B | -6.30B | -1.36B |
Financing Cash Flow | -978.50M | -987.30M | -848.64M | -756.00M | 6.77B | -494.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | ₹91.16B | 44.59 | ― | 0.95% | 38.81% | 6.85% | |
65 Neutral | 108.15B | 15.34 | 5.89% | 2.16% | -9.06% | 125.31% | |
59 Neutral | 16.16B | 16.91 | 13.25% | ― | -39.44% | 844.50% | |
49 Neutral | 3.11B | -2.74 | -18.01% | ― | -5.35% | -99.90% | |
41 Neutral | 187.94M | -11.06 | -2.87% | ― | -75.43% | -259.89% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |
Saregama India Limited has announced an upcoming Investor Presentation scheduled for September 8, 2025, as part of the RPSG Investor Day. This presentation is intended to provide insights into the company’s current operations and future strategies, potentially impacting its market positioning and offering valuable information to stakeholders.